A direct coherence between promoter methylation and loss of RNA expression was shown by a combined DAC/TSA treatment of breast cancer cell lines, demonstrating that the SFRP2 gene was effectively demethylated and re-expressed after the treatment. Here, SFRP2 is linked to breast carcinoma.